Nu Skin Enterprises, Inc.
NUS
$7.36
-$0.085-1.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 364.49M | 445.55M | 430.15M | 439.08M | 417.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 364.49M | 445.55M | 430.15M | 439.08M | 417.31M |
| Cost of Revenue | 117.53M | 127.61M | 128.68M | 131.90M | 123.24M |
| Gross Profit | 246.96M | 317.95M | 301.46M | 307.18M | 294.06M |
| SG&A Expenses | 231.75M | 286.35M | 283.23M | 283.38M | 278.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 349.28M | 413.96M | 411.91M | 415.29M | 401.35M |
| Operating Income | 15.21M | 31.60M | 18.23M | 23.79M | 15.96M |
| Income Before Tax | 134.60M | -57.80M | 13.30M | -131.65M | 1.10M |
| Income Tax Expenses | 27.09M | -21.70M | 5.00M | -13.39M | 1.63M |
| Earnings from Continuing Operations | 107.52M | -36.11M | 8.30M | -118.26M | -533.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 107.52M | -36.11M | 8.30M | -118.26M | -533.00K |
| EBIT | 15.21M | 31.60M | 18.23M | 23.79M | 15.96M |
| EBITDA | 29.42M | 48.04M | 35.55M | 41.40M | 34.39M |
| EPS Basic | 2.16 | -0.73 | 0.17 | -2.38 | -0.01 |
| Normalized Basic EPS | 0.15 | 0.34 | 0.17 | 0.22 | 0.10 |
| EPS Diluted | 2.14 | -0.73 | 0.17 | -2.38 | -0.01 |
| Normalized Diluted EPS | 0.14 | 0.34 | 0.17 | 0.22 | 0.10 |
| Average Basic Shares Outstanding | 49.76M | 49.71M | 49.71M | 49.69M | 49.54M |
| Average Diluted Shares Outstanding | 50.33M | 49.71M | 49.73M | 49.69M | 49.54M |
| Dividend Per Share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Payout Ratio | 2.79% | -8.26% | 35.93% | -2.52% | -558.91% |